Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated and Combined Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.20.2
Condensed Consolidated and Combined Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
(Temporary Equity) Preferred Series 2 [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Common Stock Subscribed [Member]
Subscriptions Receivable [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2018 $ 373 $ 64,756,903 $ (202,115) $ (57,124,673) $ 827,037 $ 8,257,525
Balance, shares at Dec. 31, 2018 3,715,444              
Common stock and warrants issued for: Preferred Unit dividend   $ 1 19,521 (27,795) (8,273)
Common stock and warrants issued for: Preferred Unit dividend, shares 16,342              
Share-based compensation 100,707 100,707
Share-based compensation, shares              
Foreign currency translation 37,832 37,832
Non-controlling interest contributions 575,000 575,000
Non-controlling interest distributions (10,804) (10,804)
Reclassification of Minority Interest 249,104 (249,104)
Net loss (1,873,072) (115,591) (1,988,663)
Balance at Mar. 31, 2019 $ 374 65,126,235 (164,283) (59,025,540) 1,026,538 6,963,324
Balance, shares at Mar. 31, 2019 3,731,786              
Balance at Dec. 31, 2018 $ 373 64,756,903 (202,115) (57,124,673) 827,037 8,257,525
Balance, shares at Dec. 31, 2018 3,715,444              
Foreign currency translation                 (29,995)
Net loss                 (5,324,329)
Balance at Jun. 30, 2019 $ 703 71,210,203 300 (2,694,530) (232,110) (62,270,344) 909,591 6,923,813
Balance, shares at Jun. 30, 2019 7,014,023              
Balance at Mar. 31, 2019 $ 374 65,126,235 (164,283) (59,025,540) 1,026,538 6,963,324
Balance, shares at Mar. 31, 2019 3,731,786              
Common stock and warrants issued for: Preferred Unit dividend $ 1 19,097 (28,005) (8,907)
Common stock and warrants issued for: Preferred Unit dividend, shares 11,844              
Common stock and warrants issued for: Director Fees   $ 10 252,949           252,959
Common stock and warrants issued for: Director Fees, shares   104,828              
Common stock and warrants issued for: Consulting Services $ 4 117,087 117,091
Common stock and warrants issued for: Consulting Services, shares 36,765              
Common stock and warrants issued for: Accrued interest on note payable $ 1 13,839 13,840
Common stock and warrants issued for: Accrued interest on note payable, shares 8,800              
Stock issued to settle convertible debt and note payable $ 308 3,074,692 3,075,000
Stock issued to settle convertible debt and note payable, shares 3,075,000              
Subscriptions pursuant to rights offering, net 2,614,623 300 (2,694,530) (79,607)
Shareholder payment for short swing 1,676 1,676
Share-based compensation $ 5 8,704 8,709
Share-based compensation, shares 45,000              
Foreign currency translation (67,827) (67,827)
Non-controlling interest distributions (16,779) (16,779)
Reclassification of Minority Interest (18,699) (18,699)
Net loss (3,216,799) (118,867) (3,335,666)
Balance at Jun. 30, 2019 $ 703 71,210,203 300 (2,694,530) (232,110) (62,270,344) 909,591 6,923,813
Balance, shares at Jun. 30, 2019 7,014,023              
Balance at Dec. 31, 2019 $ 1,041 71,505,989 (46,437) (75,068,385) 455,781 (3,152,011)
Balance, shares at Dec. 31, 2019 10,404,342              
Common stock and warrants issued for: Preferred Unit dividend $ 246 1,528,867 (325,366) 1,203,747
Common stock and warrants issued for: Preferred Unit dividend, shares 2,414,022              
Common stock and warrants issued for: Exercise of warrants $ 4 19,519 (28,219) (8,696)
Common stock and warrants issued for: Exercise of warrants, shares 37,518              
Preferred Shares - Series 2: Issuance of shares, net of transaction costs of $95,000 $ 1,405,000
Preferred Shares - Series 2: Issuance of shares, net of transaction costs of $95,000, shares 1,500
Bifurcation of derivative liability $ (529,000)
Beneficial conversion feature (729,000) 729,000 729,000
Preferred stock deemed dividend 729,000 (729,000) (729,000)
Conversion of Series 2 preferred to common $ (416,392) $ 143 416,249 416,392
Conversion of Series 2 preferred to common, shares (713) 1,426,854              
Foreign currency translation (81,069) (81,069)
Net loss (1,921,569) 129,043 (1,792,526)
Balance at Mar. 31, 2020 $ 787 $ 1,434 73,470,624 (127,506) (77,343,539) 584,824 (3,414,163)
Balance, shares at Mar. 31, 2020 459,608 14,282,736              
Balance at Dec. 31, 2019 $ 1,041 71,505,989 (46,437) (75,068,385) 455,781 (3,152,011)
Balance, shares at Dec. 31, 2019 10,404,342              
Foreign currency translation                 (87,610)
Net loss                 (11,003,437)
Balance at Jun. 30, 2020 $ 459,608 $ 1,434 80,511,278 (134,047) (85,658,825) (310,801) (5,590,961)
Balance, shares at Jun. 30, 2020 787 14,282,736              
Balance at Mar. 31, 2020 $ 787 $ 1,434 73,470,624 (127,506) (77,343,539) 584,824 (3,414,163)
Balance, shares at Mar. 31, 2020 459,608 14,282,736              
Cash contribution of merger consideration, net transaction costs of $588,255 5,411,745 5,411,745
Contribution of warrant portion of merger consideration 1,628,909 1,628,909
Foreign currency translation (6,541) (6,541)
Reclassification of Minority Interest 805,909 (805,909)
Net loss (9,121,195) (89,716) (9,210,911)
Balance at Jun. 30, 2020 $ 459,608 $ 1,434 $ 80,511,278 $ (134,047) $ (85,658,825) $ (310,801) $ (5,590,961)
Balance, shares at Jun. 30, 2020 787 14,282,736